Clinical Trial Update: Chidamide Combined With Toripalimab in Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chidamide in combination with toripalimab for sarcoma is underway, with an unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Chidamide (chidamide)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN